Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvin Berger

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 7, 2008
Assessment of protein antibody response in patients with suspected immune deficiencyAkhilesh K Chouksey, Melvin Berger
Muscle & Nerve|November 25, 2014
Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approachMelvin Berger, Jeffrey A Allen
The Journal of Allergy and Clinical Immunology|February 8, 2005
Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout miceAicha Saadane, Jindrich Soltys, Melvin Berger
The Journal of Allergy and Clinical Immunology|May 6, 2006
Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammationAicha Saadane, Jindrich Soltys, Melvin Berger
Clinical Reviews in Allergy & Immunology|October 26, 2007
Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signalingDavid Nichols, James Chmiel, Melvin Berger
Immunology and Allergy Clinics of North America|October 23, 2008
Management of primary antibody deficiency with replacement therapy: summary of guidelinesChaim M Roifman, Melvin Berger, Luigi D Notarangelo
Clinical Reviews in Allergy & Immunology|August 7, 2002
The role of inflammation in the pathophysiology of CF lung diseaseJames F Chmiel, Melvin Berger, Michael W Konstan
Postgraduate Medicine|July 3, 2013
Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disordersRandy Broyles, Linda Rodden, Patty Riley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Functional IL-10 deficiency in the lung of cystic fibrosis (cftr(-/-)) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophagesJindrich Soltys, Tracey Bonfield, James Chmiel, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 10, 2010
Subcutaneous immunoglobulin-g replacement therapy with preparations currently available in the United States for intravenous or intramuscular use: reasons and regimensAkhilesh Chouksey, Kimberly Duff, Nancy Wasserbauer, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 7, 2008
Assessment of protein antibody response in patients with suspected immune deficiencyAkhilesh K Chouksey, Melvin Berger
Muscle & Nerve|November 25, 2014
Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approachMelvin Berger, Jeffrey A Allen
The Journal of Allergy and Clinical Immunology|February 8, 2005
Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout miceAicha Saadane, Jindrich Soltys, Melvin Berger
The Journal of Allergy and Clinical Immunology|May 6, 2006
Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammationAicha Saadane, Jindrich Soltys, Melvin Berger
Clinical Reviews in Allergy & Immunology|October 26, 2007
Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signalingDavid Nichols, James Chmiel, Melvin Berger
Immunology and Allergy Clinics of North America|October 23, 2008
Management of primary antibody deficiency with replacement therapy: summary of guidelinesChaim M Roifman, Melvin Berger, Luigi D Notarangelo
Clinical Reviews in Allergy & Immunology|August 7, 2002
The role of inflammation in the pathophysiology of CF lung diseaseJames F Chmiel, Melvin Berger, Michael W Konstan
Postgraduate Medicine|July 3, 2013
Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disordersRandy Broyles, Linda Rodden, Patty Riley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Functional IL-10 deficiency in the lung of cystic fibrosis (cftr(-/-)) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophagesJindrich Soltys, Tracey Bonfield, James Chmiel, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 10, 2010
Subcutaneous immunoglobulin-g replacement therapy with preparations currently available in the United States for intravenous or intramuscular use: reasons and regimensAkhilesh Chouksey, Kimberly Duff, Nancy Wasserbauer, et al.
Pageof 7